Amany Zekry

A/Professor of Medicine- UNSW
Associate Professor

Associate Professor Amany Zekry is a Clinical Academic at St George and Sutherland Clinical School. She is a Gastroenterologist and Hepatologist at St George Hospital. A/Professor Amany Zekry is part of the research team at the Microbiome Research Centre (MRC) She leads a research group investigating the role of the micro biome in the immunopathogenesis of liver disease and liver cancer in obesity. Our research group has published novel data on the role of adipocytokines in mediating liver injury and impairing the immune response. Presently, we are using ex-vivo experiments and animal models of obesity and liver cancer to study the effect of the microbiome on the immune/inflammatory responses.  In addition, we are commencing animal and human interventional studies to investigate the effect of manipulating the gut microbiome on the immune/inflammatory responses, and associated liver injury.  

Publications

Journal articles
add
Pirozyan MR; Nguyen N; Cameron B; Luciani F; Bull RA; Zekry A; Lloyd AR, 2019, 'Chemokine-Regulated Recruitment of Antigen-Specific T-Cell Subpopulations to the Liver in Acute and Chronic Hepatitis C Infection', Journal of Infectious Diseases, vol. 219, pp. 1430 - 1438, http://dx.doi.org/10.1093/infdis/jiy679
2019
Zekry A; Rimassa L; Kelley R; Meyer T; Ryoo B; Merle P; Park J; Blanc J; Lim H; Tran A; Borgman-Hagey A; Clary D; Wang E; Cheng A; El-Khoueiry A; Abou-Alfa G, 2019, 'Outcomes based on plasma biomarkers for the Phase III CELESTIAL trial of cabozantinib versus placebo in advanced hepatocellular carcinoma', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, Vol. 34, pp. 41 - 42, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000483843100064&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2019
Brown MA; Gellatley W; Hoffman A; Dowdell L; Camac A; Francois R; Boston B; Zekry A, 2019, 'Medical complications of homelessness: a neglected side of men’s health', Internal Medicine Journal, vol. 49, pp. 455 - 460, http://dx.doi.org/10.1111/imj.14139
2019
Nicoll AJ; Roberts SK; Lim R; Mitchell J; Weltman M; George J; Wigg A; Stuart K; Gow P; MacQuillan G; Tse E; Levy M; Sood S; Zekry A; Cheng W; Mitchell J; Skoien R; Sievert W; Strasser SI; McCaughan GW, 2019, 'Beneficial response to mycophenolate mofetil by patients with autoimmune hepatitis who have failed standard therapy, is predicted by older age and lower immunoglobulin G and INR levels', Alimentary Pharmacology and Therapeutics, vol. 49, pp. 1314 - 1322, http://dx.doi.org/10.1111/apt.15248
2019
Gong L; Zekry A, 2019, 'Transplantation Immunology', in Reference Module in Biomedical Research, Elsevier, http://dx.doi.org/10.1016/B978-0-12-801238-3.65668-4
2019
Chen F; Fryer C; Gong L; Zekry A, 2019, 'Hepatitis B virus, hepatitis C virus, the microbiome and hepatocellular carcinoma', in Eslick G (ed.), Gastrointestinal Diseases and Their Associated Infections, Elsevier, pp. 41 - 54
2019
Rees V; Behary J; Stephens C; Jebeili H; Szczesniak M; Zekry A; Freiman J, 2019, 'Alterations in metabolic risk factor profile in the transition from non-alcoholic fatty liver disease (NAFLD) to NAFLD-related hepatocellular carcinoma', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, Vol. 34, pp. 58 - 58, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000483843100091&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2019
Kharbat M; Rolls S; Pavendranathan G; Choo L; Zekry A, 2019, 'Virtual clinic for positive fecal occult blood test result: Our local experience', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, Vol. 34, pp. 238 - 238, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000483843100377&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2019
Kwon JA; Dore GJ; Grebely J; Hajarizadeh B; Guy R; Cunningham EB; Power C; Estes C; Razavi H; Gray RT; Dunlop A; Zekry A; Lloyd A; Duvnjak A; Treloar C; Tyrrell H; George J; Iversen J; Marriott K; Crooks L; Maher L; Douglas M, 2019, 'Australia on track to achieve WHO HCV elimination targets following rapid initial DAA treatment uptake: A modelling study', Journal of Viral Hepatitis, vol. 26, pp. 83 - 92, http://dx.doi.org/10.1111/jvh.13013
2019
Sud R; Tiwari N; Forner P; Dowdell L; Freiman J; Zekry A, 2018, 'General practitioners require more support to prescribe direct acting antiviral therapy for hepatitis C', Internal Medicine Journal, vol. 48, pp. 105 - 106, http://dx.doi.org/10.1111/imj.13662
2018
Brown A; Hézode C; Zuckerman E; Foster GR; Zekry A; Roberts SK; Lahser F; Durkan C; Badshah C; Zhang B; Robertson M; Wahl J; Barr E; Haber B, 2018, 'Efficacy and safety of 12 weeks of elbasvir ± grazoprevir ± ribavirin in participants with hepatitis C virus genotype 2, 4, 5 or 6 infection: The C-SCAPE study', Journal of Viral Hepatitis, vol. 25, pp. 457 - 464, http://dx.doi.org/10.1111/jvh.12801
2018
Sheppard-Law S; Zablotska-Manos I; Kermeen M; Holdaway S; Lee A; George J; Zekry A; Maher L, 2018, 'Utilisation of hepatocellular carcinoma screening in Australians at risk of hepatitis B virus-related carcinoma and prescribed anti-viral therapy', Journal of Clinical Nursing, vol. 27, pp. 2673 - 2683, http://dx.doi.org/10.1111/jocn.14367
2018
Sheppard-Law S; Zablotska-Manos I; Kermeen M; Holdaway S; Lee A; George J; Zekry A; Maher L, 2018, 'Factors associated with non-adherence to HBV antiviral therapy', Antiviral Therapy, vol. 23, pp. 425 - 433, http://dx.doi.org/10.3851/IMP3219
2018
Chidwick K; Kiss D; Gray R; Yoo J; Aufgang M; Zekry A, 2018, 'Insights into the management of chronic hepatitis C in primary care using MedicineInsight', Australian journal of general practice, vol. 47, pp. 639 - 645, http://dx.doi.org/10.31128/AJGP-02-18-4482
2018
Roberts SK; Lim R; Strasser S; Nicoll A; Gazzola A; Mitchell J; Siow W; Khoo T; Hamarneh Z; Weltman M; Gow P; Janko N; Tse E; Mishra G; Cheng EH; Levy M; Cheng W; Sood S; Skoien R; Mitchell J; Zekry A; George J; MacQuillan G; Wigg A; Stuart K; Sievert W; McCaughan G, 2018, 'Efficacy and Safety of Mycophenolate Mofetil in Patients With Autoimmune Hepatitis and Suboptimal Outcomes After Standard Therapy', Clinical Gastroenterology and Hepatology, vol. 16, pp. 268 - 277, http://dx.doi.org/10.1016/j.cgh.2017.09.063
2018
Polis S; Zablotska-Manos I; Zekry A; Maher L, 2017, 'Adherence to Hepatitis B antiviral therapy: A qualitative study', Gastroenterology Nursing, vol. 40, pp. 239 - 246, http://dx.doi.org/10.1097/SGA.0000000000000161
2017
Polis S; Zhang L; Mainali B; Pons R; Pavendranathan G; Zekry A; Fernandez R, 2017, 'Factors associated with medication adherence in patients living with cirrhosis (vol 25, pg 204, 2016)', JOURNAL OF CLINICAL NURSING, vol. 26, pp. 3751 - 3751, http://dx.doi.org/10.1111/jocn.14074
2017
Sheppard-Law S; Zablotska-Manos I; Kermeen M; Holdaway S; Lee A; Zekry A; Dore GJ; George J; Maher L, 2017, 'Factors associated with HBV virological breakthrough', Antiviral Therapy, vol. 22, pp. 53 - 60, http://dx.doi.org/10.3851/IMP3087
2017
Lubel J; Strasser S; Stuart KA; Dore G; Thompson A; Pianko S; Bollipo S; Mitchell JL; Fragomeli V; Jones T; Chivers S; Gow P; Iser D; Levy M; Tse E; Gazzola A; Cheng W; Nazareth S; Galhenage S; Wade A; Weltman M; Wigg A; MacQuillan G; Sasadeusz J; George J; Zekry A; Roberts SK, 2017, 'Real-world efficacy and safety of ritonavir-boosted paritaprevir, ombitasvir, dasabuvir ± ribavirin for hepatitis C genotype 1 – final results of the REV1TAL study', Antiviral Therapy, vol. 22, pp. 699 - 710, http://dx.doi.org/10.3851/IMP3168
2017
Aggarwal V; Day AS; Connor S; Leach ST; Brown G; Singh R; Friedman A; Zekry A; Craig PI, 2017, 'Role of capsule endoscopy and fecal biomarkers in small-bowel Crohn's disease to assess remission and predict relapse', Gastrointestinal Endoscopy, vol. 86, pp. 1070 - 1078, http://dx.doi.org/10.1016/j.gie.2017.09.011
2017
Chen FW; Zekry A, 2016, 'Elevated serum ferritin: Identifying iron overload', Medicine Today, vol. 7, pp. 51 - 52
2016
Sheppard-Law S; Zablotska-Manos I; Kermeen M; Holdaway S; Lee A; Zekry A; George J; Maher L, 2016, 'Predictors of non-adherence to HBV anti-viral therapy', in HEPATOLOGY, WILEY, Boston, MA, Vol. 64, pp. 812A - 812A, presented at 67th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD), Boston, MA, 11 November 2016 - 15 November 2016, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000385493804004&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2016
Sheppard-Law S; Zablotska-Manos I; Kermeen M; Holdaway S; Lee A; Zekry A; George J; Maher L, 2016, 'Factors associated with adherence to hepatocellular carcinoma surveillance in patients undergoing hepatitis B anti-viral therapy in Australia.', in HEPATOLOGY, WILEY, Boston, MA, Vol. 64, pp. 811A - 811A, presented at 67th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD), Boston, MA, 11 November 2016 - 15 November 2016, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000385493804001&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2016
Polis S; Zang L; Bhawana M; Pons R; Pavendranathan G; Zekry A; Fernandez R, 2016, Knowledge of Treatment and Disease Questionnaire, http://dx.doi.org/10.1037/t51934-000
2016
Keoshkerian E; Hunter M; Cameron B; Nguyen N; Sugden P; Bull R; Zekry A; Maher L; Seddiki N; Zaunders J; Kelleher A; Lloyd AR; Dolan K; Haber P; Rawlinson W; Treloar C; Dore G; Luciani F, 2016, 'Hepatitis C-specific effector and regulatory CD4 T-cell responses are associated with the outcomes of primary infection', Journal of Viral Hepatitis, vol. 23, pp. 985 - 993, http://dx.doi.org/10.1111/jvh.12576
2016
Sievert W, 2015, 'HCV-infected patients need access now to new direct-acting antiviral agents to avert liver-related deaths', MEDICAL JOURNAL OF AUSTRALIA, vol. 202, pp. VI - VI, http://dx.doi.org/10.5694/mja15.00165
2015
Zeuzem S; Flisiak R; Vierling JM; Mazur W; Mazzella G; Thongsawat S; Abdurakhmanov D; Van Kinh N; Calistru P; Heo J; Stanciu C; Gould M; Makara M; Hsu S-J; Buggisch P; Samuel D; Mutimer D; Nault B; Merz M; Bao W; Griffel LH; Brass C; Naoumov NV, 2015, 'Randomised clinical trial: alisporivir combined with peginterferon and ribavirin in treatment-naive patients with chronic HCV genotype 1 infection (ESSENTIAL II)', ALIMENTARY PHARMACOLOGY & THERAPEUTICS, vol. 42, pp. 829 - 844, http://dx.doi.org/10.1111/apt.13342
2015
Williams KH; Viera de Ribeiro AJ; Prakoso E; Veillard AS; Shackel NA; Bu Y; Brooks B; Cavanagh E; Raleigh J; McLennan SV; McCaughan GW; Bachovchin WW; Keane FM; Zekry A; Twigg SM; Gorrell MD, 2015, 'Lower serum fibroblast activation protein shows promise in the exclusion of clinically significant liver fibrosis due to non-alcoholic fatty liver disease in diabetes and obesity', Diabetes Research and Clinical Practice, vol. 108, pp. 466 - 472, http://dx.doi.org/10.1016/j.diabres.2015.02.024
2015
Brown A; Hezode C; Zuckerman E; Foster G; Zekry A; Roberts S; Howe A; Durkan C; Badshah C; Zhang B; Robertson M; Wahl J; Barr E; Haber B, 2015, 'C-SCAPE: EFFICACY AND SAFETY OF 12 WEEKS OF GRAZOPREVIR plus /- ELBASVIR plus /- RIBAVIRIN IN PATIENTS WITH HCV GT2, 4, 5 OR 6 INFECTION', in JOURNAL OF HEPATOLOGY, ELSEVIER SCIENCE BV, Vienna, AUSTRIA, pp. S619 - S619, presented at 50th International Liver Congress of the European-Association-for-the-Study-of-the-Liver, Vienna, AUSTRIA, 22 April 2015 - 26 April 2015, http://dx.doi.org/10.1016/S0168-8278(15)30974-0
2015
Williams KH; Vieira De Ribeiro AJ; Prakoso E; Veillard AS; Shackel NA; Brooks B; Bu Y; Cavanagh E; Raleigh J; Mclennan SV; Mccaughan GW; Keane FM; Zekry A; Gorrell MD; Twigg SM, 2015, 'Circulating dipeptidyl peptidase-4 activity correlates with measures of hepatocyte apoptosis and fibrosis in non-alcoholic fatty liver disease in type 2 diabetes mellitus and obesity: A dual cohort cross-sectional study', Journal of Diabetes, vol. 7, pp. 809 - 819, http://dx.doi.org/10.1111/1753-0407.12237
2015
Zhu AX; Park JO; Ryoo B-Y; Yen C-J; Poon R; Pastorelli D; Blanc J-F; Chung HC; Baron AD; Pfiffer TEF; Okusaka T; Kubackova K; Trojan J; Sastre J; Chau I; Chang S-C; Abada PB; Yang L; Schwartz JD; Kudo M, 2015, 'Ramucirumab versus placebo as second-line treatment in patients with advanced hepatocellular carcinoma following first-line therapy with sorafenib (REACH): a randomised, double-blind, multicentre, phase 3 trial', LANCET ONCOLOGY, vol. 16, pp. 859 - 870, http://dx.doi.org/10.1016/S1470-2045(15)00050-9
2015
Roberts SK; Mitchell J; Leung R; Booth D; Bollipo S; Ostapowicz G; Sloss A; Mccaughan GW; Dore GJ; Thompson A; Crawford DH; Sievert W; Weltman M; Cheng W; George J; Angus P; Chu G; Cornwall M; Crawford D; Douglas M; Hallinan R; Haque M; Hawkin G; Jackson H; Johnson R; Kronborg I; Lee A; Leggett B; Mire ML; Levy M; Lubel J; MacQuillan G; Masson J; McCaughan G; McDonald J; McGarity B; Mollison L; Nicoll A; Ombiga J; Riordan S; Roberts S; Strasser S; Thompson A; Watson J; Wenman J; Wigg A; Zekry A, 2014, 'Distribution of interferon lambda-3 gene polymorphisms in Australian patients with previously untreated genotype 1 chronic hepatitis C: Analysis from the PREDICT and CHARIOT studies', Journal of Gastroenterology and Hepatology (Australia), vol. 29, pp. 179 - 184, http://dx.doi.org/10.1111/jgh.12424
2014
Dore GJ; Razavi H; Estes C; Thompson A; Zekry A; Roberts S; Sievert W, 2014, 'POTENTIAL IMPACT OF IMPROVED TREATMENT ON DISEASE BURDEN OF CHRONIC HEPATITIS C IN AUSTRALIA', in JOURNAL OF HEPATOLOGY, ELSEVIER SCIENCE BV, London, ENGLAND, pp. S210 - S210, presented at 49th Annual International Liver Congress of the European-Association-for-the-Study-of-the-Liver, London, ENGLAND, 09 April 2014 - 13 April 2014, http://dx.doi.org/10.1016/S0168-8278(14)60589-4
2014
Nguyen N; Hampartzoumian T; Cameron B; Palmer C; O'Toole S; Post J; Zekry A; Lloyd A, 2014, 'Regulation of T cell recruitment and inflammation in the human immunodeficiency virus/hepatitis C virus coinfected liver', Journal of Gastroenterology and Hepatology (Australia), vol. 29, pp. 1535 - 1543, http://dx.doi.org/10.1111/jgh.12543
2014
Muir AJ; Arora S; Everson G; Flisiak R; George J; Ghalib R; Gordon SC; Gray T; Greenbloom S; Hassanein T; Hillson J; Horga MA; Jacobson IM; Jeffers L; Kowdley KV; Lawitz E; Lueth S; Rodriguez-Torres M; Rustgi V; Shemanski L; Shiffman ML; Srinivasan S; Vargas HE; Vierling JM; Xu D; Lopez-Talavera JC; Zeuzem S, 2014, 'A randomized phase 2b study of peginterferon lambda-1a for the treatment of chronic HCV infection', JOURNAL OF HEPATOLOGY, vol. 61, pp. 1238 - 1246, http://dx.doi.org/10.1016/j.jhep.2014.07.022
2014
Nguyen N; de Esch C; Cameron B; Kumar RK; Zekry A; Lloyd AR, 2014, 'Positioning of leukocyte subsets in the portal and lobular compartments of hepatitis C virus-infected liver correlates with local chemokine expression', Journal of Gastroenterology and Hepatology (Australia), vol. 29, pp. 860 - 869, http://dx.doi.org/10.1111/jgh.12462
2014
Raghuraman S; Lloyd AR; Zekry A, 2014, 'Obese visceral adipose tissue exhibits altered T cell trafficking patterns and confers a unique phenotype to tissue-resident T cells', JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, vol. 29, pp. 23 - 23, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000343863000048&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2014
Sievert W; Razavi H; Estes C; Thompson AJ; Zekry A; Roberts SK; Dore GJ, 2014, 'Enhanced antiviral treatment efficacy and uptake in preventing the rising burden of hepatitis C-related liver disease and costs in Australia', Journal of Gastroenterology and Hepatology (Australia), vol. 29, pp. 1 - 9, http://dx.doi.org/10.1111/jgh.12677
2014
Martinez D; Palmer C; Simar D; Cameron B; Nguyen N; Aggarwal V; Lloyd A; Zekry A, 2014, 'Characterization of the cytokine milieu associated with the upregulation of IL-6 and suppressor of cytokine 3 in chronic hepatitis C treatment non-responders', Liver International, vol. 35, pp. 463 - 472, http://dx.doi.org/10.1111/liv.12473
2014
Bruggmann P; Berg T; Øvrehus ALH; Moreno C; Brandão Mello CE; Roudot-Thoraval F; Marinho RT; Sherman M; Ryder SD; Sperl J; Akarca U; Balık I; Bihl F; Bilodeau M; Blasco AJ; Buti M; Calinas F; Calleja JL; Cheinquer H; Christensen PB; Clausen M; Coelho HSM; Cornberg M; Cramp ME; Dore GJ; Doss W; Duberg AS; El-Sayed MH; Ergör G; Esmat G; Estes C; Falconer K; Félix J; Ferraz MLG; Ferreira PR; Frankova S; García-Samaniego J; Gerstoft J; Giria JA; Gonçales FL; Gower E; Gschwantler M; Guimarães Pessôa M; Hézode C; Hofer H; Husa P; Idilman R; Kåberg M; Kaita KDE; Kautz A; Kaymakoglu S; Krajden M; Krarup H; Laleman W; Lavanchy D; Lázaro P; Marotta P; Mauss S; Mendes Correa MC; Müllhaupt B; Myers RP; Negro F; Nemecek V; Örmeci N; Parkes J; Peltekian KM; Ramji A; Razavi H; Reis N; Roberts SK; Rosenberg WM; Sarmento-Castro R; Sarrazin C; Semela D; Shiha GE; Sievert W; Stärkel P; Stauber RE; Thompson AJ; Urbanek P; van Thiel I; Van Vlierberghe H; Vandijck D; Vogel W; Waked I; Wedemeyer H; Weis N; Wiegand J; Yosry A; Zekry A; Van Damme P; Aleman S; Hindman SJ, 2014, 'Historical epidemiology of hepatitis C virus (HCV) in selected countries', Journal of viral hepatitis, vol. 21, pp. 5 - 33, http://dx.doi.org/10.1111/jvh.12247
2014
Razavi H; Waked I; Sarrazin C; Myers RP; Idilman R; Calinas F; Vogel W; Mendes Correa MC; Hézode C; Lázaro P; Akarca U; Aleman S; Balık I; Berg T; Bihl F; Bilodeau M; Blasco AJ; Brandão Mello CE; Bruggmann P; Buti M; Calleja JL; Cheinquer H; Christensen PB; Clausen M; Coelho HSM; Cramp ME; Dore GJ; Doss W; Duberg AS; El-Sayed MH; Ergör G; Esmat G; Falconer K; Félix J; Ferraz MLG; Ferreira PR; Frankova S; García-Samaniego J; Gerstoft J; Giria JA; Gonçales FL; Gower E; Gschwantler M; Guimarães Pessôa M; Hindman SJ; Hofer H; Husa P; Kåberg M; Kaita KDE; Kautz A; Kaymakoglu S; Krajden M; Krarup H; Laleman W; Lavanchy D; Marinho RT; Marotta P; Mauss S; Moreno C; Murphy K; Negro F; Nemecek V; Örmeci N; Øvrehus ALH; Parkes J; Pasini K; Peltekian KM; Ramji A; Reis N; Roberts SK; Rosenberg WM; Roudot-Thoraval F; Ryder SD; Sarmento-Castro R; Semela D; Sherman M; Shiha GE; Sievert W; Sperl J; Stärkel P; Stauber RE; Thompson AJ; Urbanek P; Van Damme P; van Thiel I; Van Vlierberghe H; Vandijck D; Wedemeyer H; Weis N; Wiegand J; Yosry A; Zekry A; Cornberg M; Müllhaupt B; Estes C, 2014, 'The present and future disease burden of hepatitis C virus (HCV) infection with today's treatment paradigm', Journal of viral hepatitis, vol. 21, pp. 34 - 59, http://dx.doi.org/10.1111/jvh.12248
2014
Polis S; Zhang L; Zekry A; Fernandez R, 2014, 'Factors associated with medication adherence in patients living with cirrhosis', in HEPATOLOGY, WILEY-BLACKWELL, Boston, MA, pp. 334A - 334A, presented at 65th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases, Boston, MA, 07 November 2014 - 11 November 2014, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000344483801201&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2014
Polis SJ; Paven G; Zekry A; Zhang L, 2014, 'Factors associated with medication adherence in patients living with cirrhosis', Boston, Vol. 25, pp. 204 - 212, presented at American Association Society for Liver Disease (AASLD) Liver meeting, Boston, 07 November 2014 - 10 November 2014, http://dx.doi.org/10.1111/jocn.13083
2014
Wedemeyer H; Duberg AS; Buti M; Rosenberg WM; Frankova S; Esmat G; Örmeci N; Van Vlierberghe H; Gschwantler M; Akarca U; Aleman S; Balık I; Berg T; Bihl F; Bilodeau M; Blasco AJ; Brandão Mello CE; Bruggmann P; Calinas F; Calleja JL; Cheinquer H; Christensen PB; Clausen M; Coelho HSM; Cornberg M; Cramp ME; Dore GJ; Doss W; El-Sayed MH; Ergör G; Estes C; Falconer K; Félix J; Ferraz MLG; Ferreira PR; García-Samaniego J; Gerstoft J; Giria JA; Gonçales FL; Guimarães Pessôa M; Hézode C; Hindman SJ; Hofer H; Husa P; Idilman R; Kåberg M; Kaita KDE; Kautz A; Kaymakoglu S; Krajden M; Krarup H; Laleman W; Lavanchy D; Lázaro P; Marinho RT; Marotta P; Mauss S; Mendes Correa MC; Moreno C; Müllhaupt B; Myers RP; Nemecek V; Øvrehus ALH; Parkes J; Peltekian KM; Ramji A; Razavi H; Reis N; Roberts SK; Roudot-Thoraval F; Ryder SD; Sarmento-Castro R; Sarrazin C; Semela D; Sherman M; Shiha GE; Sperl J; Stärkel P; Stauber RE; Thompson AJ; Urbanek P; Van Damme P; van Thiel I; Vandijck D; Vogel W; Waked I; Weis N; Wiegand J; Yosry A; Zekry A; Negro F; Sievert W; Gower E, 2014, 'Strategies to manage hepatitis C virus (HCV) disease burden', Journal of viral hepatitis, vol. 21, pp. 60 - 89, http://dx.doi.org/10.1111/jvh.12249
2014
Gorrell MD; Williams KH; De Ribeiro AJV; Chowdhury S; Hamson E; Schilling O; Prakoso E; Shackel NA; Mclennan SV; Bachovchin WW; Keane FM; Mccaughan GW; Zekry A; Twigg SM, 2014, 'The protease fibroblast activation protein (FAP) in liver disease', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY-BLACKWELL, pp. 6 - 6, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000343863000013&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2014
Gorrell MD; Williams KH; de Ribeiro AJV; Chowdhury S; Hamson EJ; Schilling O; Prakoso E; Shackel NA; McLennan SV; Bachovchin WW; Keane FM; McCaughan GW; Zekry A; Twigg S, 2014, 'The Protease Fibroblast Activation Protein (FAP) in Liver Disease', in HEPATOLOGY, WILEY-BLACKWELL, Boston, MA, pp. 592A - 592A, presented at 65th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases, Boston, MA, 07 November 2014 - 11 November 2014, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000344483802309&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2014
Baharuddin B; Simar D; Lloyd AR; Zekry A, 2013, 'Impaired T cell glucose metabolism during chronic hepatitis C virus infection', in Narci T (ed.), Journal of Gastroenterology and Hepatology, Wiley Online, Melbourne, Australia, pp. 171 - 171, presented at Australian Gastroenterology Week 2013, Melbourne, Australia, 07 October 2013 - 09 October 2013, http://dx.doi.org/10.1111/jgh.12365_14
2013
Baharuddin B; Zekry A; Simar D; Palmer C; Lloyd A, 2012, 'IMPAIRED T-CELL GLUCOSE METABOLISM DURING CHRONIC HEPATITIS C VIRUS INFECTION', in JOURNAL OF HEPATOLOGY, ELSEVIER SCIENCE BV, Barcelona, SPAIN, pp. S302 - S302, presented at 47th Annual Meeting of the European-Association-for-the-Study-of-the-Liver (EASL), Barcelona, SPAIN, 18 April 2012 - 22 April 2012, http://dx.doi.org/10.1016/S0168-8278(12)60782-X
2012
Guirgis M; Nusair F; Bu YM; Yan KK; Zekry A, 2012, 'Barriers Faced by Migrants in Accessing Healthcare for Viral Hepatitis Infection.', Internal Medicine Journal, vol. 42, pp. 491 - 496, http://dx.doi.org/10.1111/j.1445-5994.2011.02647.x
2012
Guirgis M; Yan KK; Bu YM; Zekry A, 2012, 'General practitioners' knowledge and management of viral hepatitis in the migrant population.', Internal Medicine Journal, vol. 42, pp. 497 - 504, http://dx.doi.org/10.1111/j.1445-5994.2011.02440.x
2012
Ghaly S; Gill RS; Keegan MJ; Angus PW; George J; Nicoll AJ; Law M; Sinclair M; Lim LY; Ratnayake H; Dunn A; Strasser SI; Zekry A, 2012, 'Hepatocellular Carcinoma Risk In Chronic Hepatitis B Patients Achieving Viral Suppression With Antiviral Therapy', in HEPATOLOGY, WILEY-BLACKWELL, Boston, MA, pp. 354A - 354A, presented at 63rd Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD), Boston, MA, 09 November 2012 - 13 November 2012, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000310955601331&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2012
Yan K; Zekry A, 2011, 'Standard Therapy for Genotypes 2/3', Advanced Therapy for Hepatitis C, pp. 90 - 96, http://dx.doi.org/10.1002/9781444346343.ch12
2011
Patel K; Jhaveri R; George J; Qiang G; Kenedi C; Brown K; Cates C; Zekry A; Tillmann HL; Elliott L; Kilaru R; Albrecht J; Conrad A; McHutchison J, 2011, 'Open-label, ascending dose, prospective cohort study evaluating the antiviral efficacy of Rosuvastatin therapy in serum and lipid fractions in patients with chronic hepatitis C', Journal of Viral Hepatitis, vol. 18, pp. 331 - 337, http://dx.doi.org/10.1111/j.1365-2893.2010.01310.x
2011
Nelson DR; Benhamou Y; Chuang W-L; Lawitz EJ; Rodriguez-Torres M; Flisiak R; Rasenack JWF; Kryczka W; Lee C-M; Bain VG; Pianko S; Patel K; Cronin PW; Pulkstenis E; Subramanian GM; Mchutchison JG, 2010, 'Albinterferon Alfa-2b Was Not Inferior to Pegylated Interferon-alpha in a Randomized Trial of Patients With Chronic Hepatitis C Virus Genotype 2 or 3', GASTROENTEROLOGY, vol. 139, pp. 1267 - +, http://dx.doi.org/10.1053/j.gastro.2010.06.062
2010
Palmer CS; DeHart M; Zhang X; Feilotter H; Lloyd AR; Zekry A, 2010, 'SERUM PROTEOMIC PROFILES ASSOCIATED WITH IL28B GENOTYPE AMONG CHC PATIENTS', in HEPATOLOGY, WILEY-BLACKWELL, Boston, MA, pp. 727A - 728A, presented at 61st Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases, Boston, MA, 29 October 2010 - 02 November 2010, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000288775601164&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2010
Palmer CS; DeHart M; Zhang X; Feilotter H; Lloyd AR; Zekry A, 2010, 'HEPATIC MICRORNA 135A*REGULATES HEPATIC TRIGLYCERIDE STORAGE AND IS REPRESSED DURING HCV INFECTION', in HEPATOLOGY, WILEY-BLACKWELL, Boston, MA, pp. 727A - 727A, presented at 61st Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases, Boston, MA, 29 October 2010 - 02 November 2010, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000288775601163&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2010
Zeuzem S; Sulkowski MS; Lawitz EJ; Rustgi VK; Rodriguez-Torres M; Bacon BR; Grigorescu M; Tice AD; Lurie Y; Cianciara J; Muir AJ; Cronin PW; Pulkstenis E; Subramanian GM; Mchutchison JG, 2010, 'Albinterferon Alfa-2b Was Not Inferior to Pegylated Interferon-alpha in a Randomized Trial of Patients With Chronic Hepatitis C Virus Genotype 1', GASTROENTEROLOGY, vol. 139, pp. 1257 - 1266, http://dx.doi.org/10.1053/j.gastro.2010.06.066
2010
Palmer CS; Dehart M; Zhang X; Feilotter H; Lloyd A; Zekry A, 2010, 'miR-135a*plays a key role in regulating lipogenesis and inflammation in liver diseases', JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, vol. 25, pp. A128 - A128, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000283321200338&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2010
Zekry A, 2009, 'Cytokines and liver injury in chronic HCV genotype 4 infection', Journal of Gastroenterology and Hepatology, vol. 24, pp. 332 - 335, http://dx.doi.org/10.1111/j.1440-1746.2009.05815.x
2009
Palmer CS; Zhang X; Feilotter H; Lloyd AR; Zekry A, 2009, 'THE MICRORNA MIR-923 IS HIGHLY ABUNDANT AND DIFFERENTIALLY EXPRESSED BETWEEN NORMAL AND FATTY LIVERS', in HEPATOLOGY, JOHN WILEY & SONS INC, Boston, MA, pp. 1185A - 1185A, presented at 60th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases, Boston, MA, 30 October 2009 - 03 November 2009, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000270456001904&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2009
Aggarwal V; Palmer CS; Yan KK; Lloyd AR; Zekry A, 2009, 'STATINS AND LIVER INJURY IN MORBIDLY OBESE SUBJECTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE', in HEPATOLOGY, JOHN WILEY & SONS INC, Boston, MA, pp. 789A - 789A, presented at 60th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases, Boston, MA, 30 October 2009 - 03 November 2009, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000270456001029&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2009
Yan KK; Palmer CS; Lloyd AR; Zekry A, 2009, 'RELATIONSHIP OF RETINOL BINDING PROTEIN-4 WITH LIVER INJURY IN MORBIDLY OBESE SUBJECTS', in HEPATOLOGY, JOHN WILEY & SONS INC, Boston, MA, pp. 789A - 789A, presented at 60th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases, Boston, MA, 30 October 2009 - 03 November 2009, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000270456001030&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2009
Palmer CS; Lloyd AR; Zekry A, 2009, 'HEPATIC MICRORNAS EXPRESSION IN OBESE SUBJECTS WITH CHRONIC HCV', in HEPATOLOGY, JOHN WILEY & SONS INC, Boston, MA, pp. 940A - 940A, presented at 60th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases, Boston, MA, 30 October 2009 - 03 November 2009, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000270456001376&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2009
Guirgis M; Zekry A; Yan K; Bu YM; Lee A, 2009, 'Chronic hepatitis B infection in an Australian antenatal population: Seroprevalence and opportunities for better outcomes', Journal of Gastroenterology and Hepatology (Australia), vol. 24, pp. 998 - 1001, http://dx.doi.org/10.1111/j.1440-1746.2009.05841.x
2009
Nguyen N; Palmer C; Hampartzoumian T; Post J; Zekry A; Lloyd A, 2009, 'Intrahepatic chemokine expression and CD8+T cells in HIV/HCV co-infection compared to HCV mono-infection', JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, vol. 24, pp. A289 - A289, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000270551200187&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2009
Palmer C; Zhang X; Feilotter H; Lloyd A; Zekry A, 2009, 'Hepatic micrornas expression in obese subjects with chronic HCV', JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, vol. 24, pp. A285 - A285, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000270551200178&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2009
Nguyen N; De Esch C; Hampartzoumian T; Zekry A; Lloyd A, 2009, 'Fine positioning of T cell sub-populations in the chronic HCV-infected liver', JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, vol. 24, pp. A284 - A284, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000270551200175&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2009
Yan KK; Dinihan I; Freiman J; Zekry A, 2008, 'Sarcoidosis presenting with granulomatous uveitis induced by pegylated interferon and ribavirin therapy for hepatitis C', Internal Medicine Journal, vol. 38, pp. 207 - 210, http://dx.doi.org/10.1111/j.1445-5994.2007.01625.x
2008
Zekry A; Freiman J, 2008, 'Eltrombopag: Is this "24 karat gold platelet" treatment for thrombocytopenia in cirrhosis associated with hepatitis C?', Hepatology, vol. 47, pp. 1418 - 1421, http://dx.doi.org/10.1002/hep.22300
2008
Palmer C; Hampartzoumian T; Lloyd AR; Zekry A, 2008, 'A novel role for adiponectin in regulating the immune responses in chronic hepatitis C virus infection', Hepatology, vol. 48, pp. 374 - 384, http://dx.doi.org/10.1002/hep.22387
2008
Li SYW; Yan KK; Palmer C; Guirgis M; Bu Y; Zekry A, 2008, 'High retinol binding protein-4 and low adiponectin levels are associated with steatosis in bariatric patients', in Journal of Gastroenterology and Hepatology, Blackwell Publishing Asia, Carlton, Victoria, Australia, pp. A285 - A285, presented at Journal of Gastroenterology and Hepatology
2008
Ward CL; Dev A; Rigby S; Symonds WT; Patel K; Zekry A; Pawlotsky JM; McHutchison JG, 2008, 'Interferon and ribavirin therapy does not select for resistance mutations in hepatitis C virus polymerase', Journal of Viral Hepatitis, vol. 15, pp. 571 - 577, http://dx.doi.org/10.1111/j.1365-2893.2008.00980.x
2008
Palmer CS; Nguyen N; Lloyd AR; Zekry A, 2008, 'EFFECT OF STEATOSIS ON THE INTRAHEPATIC CYTOKINE/CHEMOKINE RESPONSES IN CHRONIC HCV', in HEPATOLOGY, JOHN WILEY & SONS INC, San Francisco, CA, pp. 789A - 789A, presented at 59th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases, San Francisco, CA, 31 October 2008 - 04 November 2008, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000259757401463&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2008
Aggarwal V; Palmer CS; Lloyd AR; Zekry A, 2008, 'EFFECT OF OBESITY ON INTERFERON STIMULATED GENES EXPRESSION IN CHRONIC HCV INFECTION', in HEPATOLOGY, JOHN WILEY & SONS INC, San Francisco, CA, pp. 864A - 865A, presented at 59th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases, San Francisco, CA, 31 October 2008 - 04 November 2008, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000259757401628&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2008
Choo L; Morris DL; Chu F; Liauw WS; Zekry A, 2008, 'Clinical characteristics of patients with hepatocellular carcinoma presenting to a single tertiary institute', in Journal of Gastroenterology and Hepatology, Blackwell Publishing Asia, Carlton, Victoria, Australia, pp. A279 - A279, presented at Journal of Gastroenterology and Hepatology
2008
Maher L; Dore G; Treloar C; Rawlinson W; White P; Dolan K; Zekry A; Madden A; Loveday S; Kaldor J; Lloyd A, 2008, 'Preparedness for candidate hepatitis C vaccine trials in people who inject drugs: challenges and opportunities', in Journal of Gastroenterology and Hepatology, Blackwell Publishing Asia, Carlton, Victoria, Australia, pp. A358 - A358, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000264953600072&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a
2008
Palmer C; Nguyen ND; Lloyd AR; Zekry A, 2008, 'EFFECT OF STEATOSIS ON THE INTRAHEPATIC CYTOKINE/CHEMOKINE RESPONSES IN CHRONIC HCV', in Hepatology, John Wiley & Sons Inc, Hoboken, NJ, USA, pp. 1080 - 1081, presented at Hepatology
2008
Palmer C; Nguyen ND; Lloyd AR; Zekry A, 2008, 'Effect of obesity on the intrahepatic cytokine/chemokine responses in chronic hepatitis C', in Journal of Gastroenterology and Hepatology, Blackwell Publishing Asia, Carlton, Victoria, Australia, pp. A285 - A285, presented at Journal of Gastroenterology and Hepatology, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000259960100222&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a
2008
Aggarwal V; Palmer C; Lloyd AR; Zekry A, 2008, 'EFFECT OF OBESITY ON INTERFERON STIMULATED GENES EXPRESSION IN CHRONIC HCV INFECTION', in Hepatology, John Wiley & Sons Inc, Hoboken, NJ, USA, pp. 1248 - 1249, presented at Hepatology
2008
Aggarwal V; Palmer C; Nguyen ND; Lloyd AR; Zekry A, 2008, 'Differential expression of interferon stimulating genes in obese subjects receiving treatment for chronic hepatitis C', in Journal of Gastroenterology and Hepatology, Blackwell Publishing Asia, Carlton, Victoria, Australia, pp. A282 - A282, presented at Journal of Gastroenterology and Hepatology, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000259960100215&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a
2008
Aggarwal V; Jorgenson J; Talbot ML; Loi KW; Zekry A, 2008, 'Statins may aggravate liver injury in obese subjects with nonalcoholic fatty liver disease', in Journal of Gastroenterology and Hepatology, Blackwell Publishing Asia, Carlton, Victoria, Australia, pp. A283 - A283, presented at Journal of Gastroenterology and Hepatology, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000259960100218&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a
2008
Yan KK; Guirgis M; Dinh T; George J; Dev A; Lee A; Zekry A, 2008, 'Treatment responses in Asians and Caucasians with chronic hepatitis C infection', World Journal of Gastroenterology, vol. 14, pp. 3416 - 3420, http://dx.doi.org/10.3748/wjg.14.3416
2008
Dev A; Kauf T; Zekry A; Patel K; Heller K; Schulman K; McHutchison J, 2008, 'Factors influencing the participation of gastroenterologists and hepatologists in clinical research', BMC Health Services Research, vol. 8, pp. 1 - 11, http://dx.doi.org/10.1186/1472-6963-8-208
2008
Zekry A; Yan KK, 2007, 'Is re-treatment with peginterferon alpha-2a and ribavirin effective in patients with relapsed chronic hepatitis C?', NATURE CLINICAL PRACTICE GASTROENTEROLOGY and HEPATOLOGY, vol. 4, pp. 12 - 13, http://dx.doi.org/10.1038/ncpgasthep0694
2007
Zekry A; Yan K, 2007, 'Is re-treatment with peginterferon alpha-2a and ribavirin effective in patients with relapsed chronic hepatitis C?', NATURE CLINICAL PRACTICE GASTROENTEROLOGY & HEPATOLOGY, vol. 4, pp. 12 - 13, http://dx.doi.org/10.1038/ncpgasthep0694
2007
White IR; Patel K; Symonds WT; Dev A; Griffin P; Tsokanas N; Skehel M; Liu C; Zekry A; Cutler P; Gattu M; Rockey DC; Berrey MM; McHutchison JG, 2007, 'Serum proteomic analysis focused on fibrosis in patients with hepatitis C virus infection', Journal of Translational Medicine, vol. 5, http://dx.doi.org/10.1186/1479-5876-5-33
2007
McHutchison JG; King JM; Zekry A, 2007, 'New Drugs for the Management of Hepatitis C', in Viral Hepatitis, pp. 540 - 552, http://dx.doi.org/10.1002/9780470987131.ch34
2007
Palmer C; Lloyd AR; Zekry A, 2007, 'Effect of adiponectin on the cellular immune response in chronic HCV infection', Hepatology, vol. 46, pp. 440A - 440A, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000249910400459&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a
2007
Zekry A; Walley N; Weale M; Ginsburg G; Goldstein D; McHutchison JG, 2007, 'Polymorphisms in adrenergic receptors, adiponcetin and adiponectin receptors influence fibrosis rates and response to therapy in chronic HCV', in HEPATOLOGY, JOHN WILEY & SONS INC, Boston, MA, pp. 440A - 440A, presented at 58th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases, Boston, MA, 02 November 2007 - 06 November 2007, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000249910400460&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2007
Yan KK; Dinihan I; Freiman J; Lawrence R; Zekry A, 2006, 'Sarcoidosis presenting with granulomatous uveitis induced by pegylated interferon and ribavirin therapy for hepatitis C', Journal of Gastroenterology and Hepatology, vol. 21, pp. A323 - A323
2006
Palmer C; Lloyd AR; Yan KK; Hampartzoumian T; Zekry A, 2006, 'Effect of adipokines on T-CELL mediated anti-HCV immune responses', Hepatology, vol. 44, pp. 297A - 298A, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000241362300290&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a
2006
Yan KK; Zekry A; Hui JM; Freiman J; George J, 2006, 'Virological responses in Asians receiving combination antiviral therapy for chronic hepatitis C virus infection', Journal of Gastroenterology and Hepatology, vol. 21, pp. A334 - A334, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000247320600173&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a
2006
Yan KK; George J; Freiman J; Craig P; Hui JM; Zekry A, 2006, 'Enhanced virological responses in genotype 4 hepatitis C virus infection: a case control study', Journal of Gastroenterology and Hepatology, vol. 21, pp. A308 - A308, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000247320600121&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a
2006
Scott D; Freiman J; Zekry A; Vonthethoff LW; Vollmer-Conner U; Hui JM, 2006, 'A novel noninvasive index for prediction of hepatic fibrosis in chronic hepatitis B virus infection', Journal of Gastroenterology and Hepatology, vol. 21, pp. A300 - A300, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000247320600105&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a
2006
Zekry A; McHutchison JG; Diehl AM, 2005, 'Insulin resistance and steatosis in hepatitis C virus infection', Gut, vol. 54, pp. 903 - 906, http://dx.doi.org/10.1136/gut.2004.059873
2005
Patel K; Zekry A; McHutchison JG, 2005, 'Steatosis and chronic hepatitis C virus infection: Mechanisms and significance', Clinics in Liver Disease, vol. 9, pp. 399 - 410, http://dx.doi.org/10.1016/j.cld.2005.05.007
2005
Zekry A; Patel K; McHutchison JG, 2005, 'Treatment of acute hepatitis C infection: More pieces of the puzzle?', Journal of Hepatology, vol. 42, pp. 293 - 296, http://dx.doi.org/10.1016/j.jhep.2004.12.012
2005
Zekry A; Gleeson M; Guney S; McCaughan GW, 2004, 'A prospective cross-over study comparing the effect of mycophenolate versus azathioprine on allograft function and viral load in liver transplant recipients with recurrent chronic HCV infection', Liver Transplantation, vol. 10, pp. 52 - 57, http://dx.doi.org/10.1002/lt.20000
2004
McHutchison J; Zekry A, 2004, 'Is the current standard therapy for hepatitis C of peginterferon and ribavirin an option for patients coinfected with HIV?', Nature Clinical Practice Gastroenterology and Hepatology, vol. 1, pp. 70 - 71, http://dx.doi.org/10.1038/ncpgasthep0050
2004
McCaughan GW; Zekry A, 2004, 'Mechanisms of HCV reinfection and allograft damage after liver transplantation', Journal of Hepatology, vol. 40, pp. 368 - 374, http://dx.doi.org/10.1016/j.jhep.2004.01.014
2004
Zekry A; Patel K; Muir A; McHutchison JG, 2004, 'Tinkering and tailoring with HCV therapy: Can we get away with less?', Hepatology, vol. 40, pp. 1249 - 1251, http://dx.doi.org/10.1002/hep.20513
2004
Zekry A; Whiting P; Crawford DH; Angus PW; Jeffrey GP; Padbury RT; Gane EJ; McCaughan GW; Koorey D; Strasser S; Verran D; Stewart G; Lynch S; Fawcett J; Strong R; Gow P; Berry R; Jones R; Dolan P; Kow L; Harley H; House A; Mictchell A; Jeffrey G; Munn S; McCall J, 2003, 'Liver transplantation for HCV-associated liver cirrhosis: Predictors of outcomes in a population with significant genotype 3 and 4 distribution', Liver Transplantation, vol. 9, pp. 339 - 347, http://dx.doi.org/10.1053/jlts.2003.50063
2003
McCaughan GW; Zekry A, 2003, 'Impact of immunosuppression on immunopathogenesis of liver damage in hepatitis C virus-infected recipients following liver transplantation', Liver Transplantation, vol. 9, http://dx.doi.org/10.1053/jlts.2003.50269
2003
McCaughan GW; Zekry A, 2002, 'Pathogenesis of hepatitis C virus recurrence in the liver allograft', Liver Transplantation, vol. 8, pp. s7 - s13, http://dx.doi.org/10.1053/jlts.2002.35856
2002
Zekry A; Bishop GA; Bowen DG; Gleeson MM; Guney S; Painter DM; McCaughan GW, 2002, 'Intrahepatic cytokine profiles associated with posttransplantation hepatitis C virus-related liver injury', Liver Transplantation, vol. 8, pp. 292 - 301, http://dx.doi.org/10.1053/jlts.2002.31655
2002
Yin JL; Shackel NA; Zekry A; McGuinness PH; Richards C; Van Der Putten K; McCaughan GW; Eris JM; Bishop GA, 2001, 'Real-time reverse transcriptase-polymerase chain reaction (RT-PCR) for measurement of cytokine and growth factor mRNA expression with fluorogenic probes or SYBR Green I', Immunology and Cell Biology, vol. 79, pp. 213 - 221, http://dx.doi.org/10.1046/j.1440-1711.2001.01002.x
2001
McCaughan GW; Zekry A, 2000, 'Effects of immunosuppression and organ transplantation on the natural history and immunopathogenesis of hepatitis C virus infection', Transplant Infectious Disease, vol. 2, pp. 166 - 185, http://dx.doi.org/10.1034/j.1399-3062.2000.020403.x
2000
Doughty AL; Zekry A; Spencer JD; Turhan S; Painter D; McCaughan GW, 2000, 'Spontaneous clearance of hepatitis C virus infection post-liver transplantation is associated with rapidly changing quasispecies: A single case report', Liver Transplantation, vol. 6, pp. 648 - 653, http://dx.doi.org/10.1053/jlts.2000.9740
2000
Freeman AJ; Zekry A; Whybin LR; Harvey CE; van Beek IA; de Kantzow SL; Rawlinson WD; Boughton CR; Robertson PW; Marinos G, 2000, 'Hepatitis C Virus prevalence and genotype among Australian injecting drug users in the 1970s.', in HEPATOLOGY, W B SAUNDERS CO, pp. 279A - 279A, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000089622400468&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2000
Williams RB; Zekry A; Cook IJ, 1999, 'The mechanisms of rumination and the role of lower esophageal sphincter (LES) relaxations.', in Gastroenterology, W B Saunders Co, Philadelphia, PA, USA, pp. A704 - A704, presented at Digestive Disease Week and the 99th Annual Meeting of the American Gastroenterological Association, New Orleans, Louisiana, USA, 17 May 1999 - 20 May 1999, http://dx.doi.org/10.1016/S0016-5085(98)82889-8
1999